Kv3.1 Interaction with UBR5 Is Required for Chronic Inflammatory Pain
Ying Zeng,Meng-Lan Sun,Di Liu,Yue Huang,Shan Xie,Ya-Xuan Zhao,Zi-Xuan Wu,Ya Liu,Gan Ma,Ling Xie,Yu-Tao Dang,Ling-Yun Hao,Qi-Hui Wang,Hong-Jun Wang,Li Yang,Zhou-Ya Xue,Zhi-Qiang Pan
DOI: https://doi.org/10.1007/s12035-024-04259-5
IF: 5.682
2024-06-13
Molecular Neurobiology
Abstract:Chronic inflammatory pain caused by neuronal hyperactivity is a common and refractory disease. Kv3.1, a member of the Kv3 family of voltage-dependent K + channels, is a major determinant of the ability of neurons to generate high-frequency action potentials. However, little is known about its role in chronic inflammatory pain. Here, we show that although Kv3.1 mRNA expression was unchanged, Kv3.1 protein expression was decreased in the dorsal spinal horn of mice after plantar injection of complete Freund's adjuvant (CFA), a mouse model of inflammatory pain. Upregulating Kv3.1 expression alleviated CFA-induced mechanical allodynia and heat hyperalgesia, whereas downregulating Kv3.1 induced nociception-like behaviors. Additionally, we found that ubiquitin protein ligase E3 component n-recognin 5 (UBR5), a key factor in the initiation of chronic pain, binds directly to Kv3.1 to drive its ubiquitin degradation. Intrathecal injection of the peptide TP-CH-401, a Kv3.1 ubiquitination motif sequence, rescued the decrease in Kv3.1 expression and Kv currents through competitive binding to UBR5, and consequently attenuated mechanical and thermal hypersensitivity. These findings demonstrate a previously unrecognized pathway of Kv3.1 abrogation by UBR5 and indicate that Kv3.1 is critically involved in the regulation of nociceptive behavior. Kv3.1 is thus a promising new target for treating inflammatory pain.
neurosciences